Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HALO: Adcetris and Levact in Elderly Hodgkin Lymphoma
NCT02467946Phase 2Completed
- Sponsor
- Centre Antoine Lacassagne
- Start
- Jan 2016
- Primary completion
- Apr 2022
- Modality
- Monoclonal Antibodies, Antibody-Drug Conjugates (ADCs), Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of brentuximab vedotin, bendamustine in Hodgkin lymphoma (HL), sponsored by Centre Antoine Lacassagne. Started Jan 2016; status: completed.
02
Drugs
brentuximab vedotinbendamustine
03
Conditions
Hodgkin lymphoma (HL)
Beyond the preview
Go deeper on NCT02467946.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02467946.